Doctor Virginia Blanco Blazquez

Doctor Virginia Blanco Blazquez

Jesus Uson Minimally Invasive Surgery Centre, Caceres (Spain)

Member of:

She studied Veterinary Medicine at the Complutense University of Madrid (UCM,Spain,2014).She joined the Cardiovascular Department of the Jesus Uson Minimally Invasive Surgery Centre (JUMISC,Cáceres,Spain). She gained a predoctoral contract belonging to the Extremadura Science System, Technology and Innovation of the Junta de Extremadura (PD16069, 2017).She defended her PhD dissertations in the Applied Biomedical Research Doctoral Program at the University of Extremadura (UEX,2018). She gained her PhD (Cum Laude), the Award "Premio Extraordinario de Doctorado" of the UEX and the Award "Premio Doctorado 2020 Ciencias Clínicas Quirúrgicas" of the Royal Academy of Medicine of Spain. Currently, she is a postdoctoral researcher and PI of a regional project (IB20191). She has colaborated in more than 20 projects, 50 communications and coauthored more than 40 scientific publications. She is accredited to perform animal experiments and as Veterinarian Director of Radiodiagnostic Facilities.

Presentations

Cardiosphere derived cell secretome therapy after experimental myocardial infarction: effects of intracoronary administration on ventricular tachycardia inducibility and cardiac function

Event: ESC Congress 2023

Topic: Arrhythmias

Session: Mechanisms of ventricular arrhythmias

Access

Microencapsulated insulin like growth factor 1 improves cardiac function after experimental infarction in absence of angiogenesis

Event: ESC Congress 2017

Topic: Ischaemia, experimental studies

Session: Best Posters in CAD: from bench to bedside

Access

Comparison of intracoronary administration of microspheres loaded with either insulin-like growth factor 1 or hepatocyte growth factor in a swine acute infarct model.

Event: ESC Congress 2017

Topic: Ischaemia, experimental studies

Session: Coronary artery disease: from bench to bedside

Access

Doctor Virginia Blanco Blazquez

Biography

Contributor content

Cardiosphere derived cell secretome therapy after experimental myocardial infarction: effects of intracoronary administration on ventricular tachycardia inducibility and cardiac function

Microencapsulated insulin like growth factor 1 improves cardiac function after experimental infarction in absence of angiogenesis

Comparison of intracoronary administration of microspheres loaded with either insulin-like growth factor 1 or hepatocyte growth factor in a swine acute infarct model.

ESC 365 is supported by